Terminated NA INTERVENTIONAL 1-arm NCT03085641

Treatment of Central Sleep Apnoea in Patients With Heart Failure With Nasal High Flow Therapy (nHFT) (RELAX)

Treatment of Central Sleep Apnoea and Cheyne Stokes Respiration in Patients With Heart Failure: Nasal High-flow Oxygen Therapy?

Sponsor: University Medical Center Groningen

Conditions Central Sleep Apnea Cheyne-Stokes Respiration

Interventions Nasal high flow oxygen therapy

Updated 7 times since 2017 Last updated: Dec 13, 2018 Started: Jun 15, 2017 Primary completion: Oct 18, 2018 Completion: Oct 18, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Side effects

Other terminated trials from University Medical Center Groningen

See all terminations from University Medical Center Groningen

This NA trial investigates Central Sleep Apnea and Cheyne-Stokes Respiration and is currently terminated or withdrawn. University Medical Center Groningen leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jan 2019 — Jan 2021 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jun 2018 — Jan 2019 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Nov 2017 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Apr 2017 — Nov 2017 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Medical Center Groningen

Data source: University Medical Center Groningen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Groningen, Netherlands